Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel D Shapiro

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Computers in Biology and Medicine|May 15, 2026
Toward protocol simplification: Deep learning-based image synthesis in three-phase CT urographyHongkun Yu, Syed Jamal Safdar Gardezi, E Jason Abel, et al.
Nature Reviews. Urology|April 7, 2021
Optimizing the diagnosis and management of ductal prostate cancerWeranja Ranasinghe, Daniel D Shapiro, Miao Zhang, et al.
Urologic Oncology|September 23, 2021
Tumor diameter response in patients with metastatic clear cell renal cell carcinoma is associated with overall survivalAlberto C Pieretti, Daniel D Shapiro, Mary E Westerman, et al.
European Urology Oncology|November 24, 2023
Reply to Eduard Roussel, Riccardo Bertolo, Chiara Ciccarese, et al's Letter to the Editor re: E. Jason Abel, Viraj A. Master, Philippe E. Spiess, et al. The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic Features. Eur Urol Oncol. 2023;6:266-274E Jason Abel, Viraj A Master, Philippe E Spiess, et al.
European Urology Oncology|July 13, 2023
The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic FeaturesE Jason Abel, Viraj A Master, Philippe E Spiess, et al.
European Urology Open Science|March 2, 2023
Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free IntervalsDaniel D Shapiro, Jose A Karam, Logan Zemp, et al.
Urologic Oncology|July 24, 2021
Sarcomatoid features and lymph node-positive disease in chromophobe renal cell carcinomaAlberto C Pieretti, Mary E Westerman, Alexandria Childs, et al.
Urology|March 13, 2026
The Staging of High-risk And non-metastatic Renal cell carcinoma Preoperatively (SHARP) Model predicts pathologic T3 stage for neoadjuvant clinical trial enrollmentPaz Lotan, Andrew L Wentland, Daniel D Shapiro, et al.
Urologic Oncology|July 5, 2025
Vigorous physical activity as a potential environmental risk factor in renal medullary carcinomaDaniel D Shapiro, Sagar S Mukhida, Andrew W Hahn, et al.
Urology|August 12, 2020
Patterns of Initial Metastatic Recurrence After Surgery for High-Risk Nonmetastatic Renal Cell CarcinomaLeo D Dreyfuss, Viraj A Master, Jay D Raman, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Computers in Biology and Medicine|May 15, 2026
Toward protocol simplification: Deep learning-based image synthesis in three-phase CT urographyHongkun Yu, Syed Jamal Safdar Gardezi, E Jason Abel, et al.
Nature Reviews. Urology|April 7, 2021
Optimizing the diagnosis and management of ductal prostate cancerWeranja Ranasinghe, Daniel D Shapiro, Miao Zhang, et al.
Urologic Oncology|September 23, 2021
Tumor diameter response in patients with metastatic clear cell renal cell carcinoma is associated with overall survivalAlberto C Pieretti, Daniel D Shapiro, Mary E Westerman, et al.
European Urology Oncology|November 24, 2023
Reply to Eduard Roussel, Riccardo Bertolo, Chiara Ciccarese, et al's Letter to the Editor re: E. Jason Abel, Viraj A. Master, Philippe E. Spiess, et al. The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic Features. Eur Urol Oncol. 2023;6:266-274E Jason Abel, Viraj A Master, Philippe E Spiess, et al.
European Urology Oncology|July 13, 2023
The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic FeaturesE Jason Abel, Viraj A Master, Philippe E Spiess, et al.
European Urology Open Science|March 2, 2023
Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free IntervalsDaniel D Shapiro, Jose A Karam, Logan Zemp, et al.
Urologic Oncology|July 24, 2021
Sarcomatoid features and lymph node-positive disease in chromophobe renal cell carcinomaAlberto C Pieretti, Mary E Westerman, Alexandria Childs, et al.
Urology|March 13, 2026
The Staging of High-risk And non-metastatic Renal cell carcinoma Preoperatively (SHARP) Model predicts pathologic T3 stage for neoadjuvant clinical trial enrollmentPaz Lotan, Andrew L Wentland, Daniel D Shapiro, et al.
Urologic Oncology|July 5, 2025
Vigorous physical activity as a potential environmental risk factor in renal medullary carcinomaDaniel D Shapiro, Sagar S Mukhida, Andrew W Hahn, et al.
Urology|August 12, 2020
Patterns of Initial Metastatic Recurrence After Surgery for High-Risk Nonmetastatic Renal Cell CarcinomaLeo D Dreyfuss, Viraj A Master, Jay D Raman, et al.
Pageof 7